1213 related articles for article (PubMed ID: 8728878)
21. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
22. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
[TBL] [Abstract][Full Text] [Related]
23. N-Methyl-D-aspartate receptor antagonist d-AP5 prevents pertussis toxin-induced alterations in rat spinal cords by inhibiting increase in concentrations of spinal CSF excitatory amino acids and downregulation of glutamate transporters.
Wong CS; Wu GJ; Chen WF; Jean YH; Hung CH; Lin CS; Huang SY; Wen ZH
Brain Res Bull; 2009 Aug; 80(1-2):69-74. PubMed ID: 19463918
[TBL] [Abstract][Full Text] [Related]
24. Differential mechanisms of Ca2+ responses in glial cells evoked by exogenous and endogenous glutamate in rat hippocampus.
Latour I; Gee CE; Robitaille R; Lacaille JC
Hippocampus; 2001; 11(2):132-45. PubMed ID: 11345120
[TBL] [Abstract][Full Text] [Related]
25. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
26. AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.
Gartside SE; Cole AJ; Williams AP; McQuade R; Judge SJ
Eur J Neurosci; 2007 May; 25(10):3001-8. PubMed ID: 17509083
[TBL] [Abstract][Full Text] [Related]
27. L-2-chloropropionic acid-induced neurotoxicity is prevented by MK-801: possible role of NMDA receptors in the neuropathology.
Widdowson PS; Wyatt I; Gyte A; Simpson MG; Lock EA
Toxicol Appl Pharmacol; 1996 Jan; 136(1):138-45. PubMed ID: 8560467
[TBL] [Abstract][Full Text] [Related]
28. Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation.
Liu J; Moghaddam B
J Pharmacol Exp Ther; 1995 Sep; 274(3):1209-15. PubMed ID: 7562490
[TBL] [Abstract][Full Text] [Related]
29. Excitatory amino acid receptors and neurodegeneration.
Doble A
Therapie; 1995; 50(4):319-37. PubMed ID: 7482387
[TBL] [Abstract][Full Text] [Related]
30. [Synaptic mechanisms of excitatory amino acids and NMDA receptor mediated brain excitability].
Yamamura T; Kemmotsu O
Masui; 1990 Nov; 39(11):1448-59. PubMed ID: 2177110
[TBL] [Abstract][Full Text] [Related]
31. Cloning of cDNA for the glutamate-binding subunit of an NMDA receptor complex.
Kumar KN; Tilakaratne N; Johnson PS; Allen AE; Michaelis EK
Nature; 1991 Nov; 354(6348):70-3. PubMed ID: 1719427
[TBL] [Abstract][Full Text] [Related]
32. NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys.
Yang CC; Chien CT; Wu MH; Ma MC; Chen CF
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1433-40. PubMed ID: 18272600
[TBL] [Abstract][Full Text] [Related]
33. Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors.
Bashir ZI; Bortolotto ZA; Davies CH; Berretta N; Irving AJ; Seal AJ; Henley JM; Jane DE; Watkins JC; Collingridge GL
Nature; 1993 May; 363(6427):347-50. PubMed ID: 8388549
[TBL] [Abstract][Full Text] [Related]
34. Glutamate and regulation of proliferation in the developing mammalian telencephalon.
Luk KC; Sadikot AF
Dev Neurosci; 2004; 26(2-4):218-28. PubMed ID: 15711062
[TBL] [Abstract][Full Text] [Related]
35. Receptor and voltage-operated ion channels in the central nervous system.
Antkiewicz-Michaluk L
Pol J Pharmacol; 1995; 47(3):253-64. PubMed ID: 8714758
[TBL] [Abstract][Full Text] [Related]
36. The effects of polyamine agonists and antagonists on N-methyl-D-aspartate-induced depolarizations of amphibian motoneurons in situ.
Hackman JC; Holohean AM
Brain Res; 2010 Apr; 1325():10-8. PubMed ID: 20156426
[TBL] [Abstract][Full Text] [Related]
37. Neurotoxicity and excitatory amino acid antagonists.
Schousboe A; Frandsen A; Wahl P; Krogsgaard-Larsen P
Neurotoxicology; 1994; 15(3):477-81. PubMed ID: 7854581
[TBL] [Abstract][Full Text] [Related]
38. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy.
McDonald JW; Garofalo EA; Hood T; Sackellares JC; Gilman S; McKeever PE; Troncoso JC; Johnston MV
Ann Neurol; 1991 May; 29(5):529-41. PubMed ID: 1650160
[TBL] [Abstract][Full Text] [Related]
39. Endogenous excitatory amino acids and glutamate receptor subtypes involved in the control of hypothalamic luteinizing hormone-releasing hormone secretion.
López FJ; Donoso AO; Negro-Vilar A
Endocrinology; 1992 Apr; 130(4):1986-92. PubMed ID: 1312433
[TBL] [Abstract][Full Text] [Related]
40. Activation-related and activation-independent effects of polyamines on phencyclidine receptor binding within the N-methyl-D-aspartate receptor complex.
Javitt DC; Frusciante MJ; Zukin SR
J Pharmacol Exp Ther; 1994 Aug; 270(2):604-13. PubMed ID: 7915316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
